Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Data-driven miRNA classifier as response predictor for immune checkpoint inhibitor treatment in advanced-stage cancer patients

Date

24 Nov 2019

Session

Mini Oral session - Immunotherapy of cancer

Presenters

Chia-Hsun Hsieh

Citation

Annals of Oncology (2019) 30 (suppl_9): ix107-ix114. 10.1093/annonc/mdz438

Authors

C. Hsieh1, S. Kang2, W. Chen2, Y. Lin1, H. Wang3, J. Chen1, Y. Hsieh2, E.P. Yang2

Author affiliations

  • 1 Hematology-oncology, Chang Gung Memorial Hospital, 333 - Taoyuan/TW
  • 2 Business Development, Quark Biosciences, Inc., 30261 - Hsinchu City/TW
  • 3 Oncology, Chang Gung Memorial Hospital, 333 - Taoyuan/TW
More

Resources

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings